CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1998; 48:331
doi: 10.3322/canjclin.48.6.331
© 1998 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prados, M. D.
Right arrow Articles by Wilson, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prados, M. D.
Right arrow Articles by Wilson, C. B.

CA: A Cancer Journal for Clinicians, Vol 48, Issue 6 331-360, Copyright © 1998 by American Cancer Society

ARTICLES

Primary central nervous system tumors: advances in knowledge and treatment

M. D. Prados, M. S. Berger and C. B. Wilson
Department of Neurological Surgery, University of California San Francisco, USA.

The ability to diagnose, monitor, and treat CNS tumors has been improved by new imaging techniques such as positron emission tomography (PET) scanning and functional MR imaging, stereotactic surgery, delivery of radiotherapy with brachytherapy and radiosurgery, and novel methods for delivering chemotherapy. These innovations combined with the new information about tumor pathogenesis and behavior revealed by molecular research give hope that more specific treatments for malignant CNS tumors will be developed in the future.


This article has been cited by other articles:


Home page
 JCOHome page
G. Gatta, R. Capocaccia, C. Stiller, P. Kaatsch, F. Berrino, M. Terenziani, and the EUROCARE Working Group
Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
J. Clin. Oncol., June 1, 2005; 23(16): 3742 - 3751.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
G. G. Gomez, S. B. Read, L. E. Gerschenson, D. Santoli, A. Zweifach, and C. A. Kruse
Interactions of the allogeneic effector leukemic T cell line, TALL-104, with human malignant brain tumors
Neuro-oncol, April 1, 2004; 6(2): 83 - 95.
[Abstract] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
D. L. Preston, E. Ron, S. Yonehara, T. Kobuke, H. Fujii, M. Kishikawa, M. Tokunaga, S. Tokuoka, and K. Mabuchi
Tumors of the Nervous System and Pituitary Gland Associated With Atomic Bomb Radiation Exposure
J Natl Cancer Inst, October 16, 2002; 94(20): 1555 - 1563.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger
Epidemiology of primary brain tumors: Current concepts and review of the literature
Neuro-oncol, October 1, 2002; 4(4): 278 - 299.
[Abstract] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
J. M. Legler, L. A. G. Ries, M. A. Smith, J. L. Warren, E. F. Heineman, R. S. Kaplan, and M. S. Linet
Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality
J Natl Cancer Inst, August 18, 1999; 91(16): 1382 - 1390.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by American Cancer Society.